Monte Rosa Therapeutics Inc 's Revenue per employee fell on a trailing twelve month basis to $ 286,353, below the company average number of $845,842.
Within the Healthcare sector Employees of 261 other companies have achieved higher revenue per employee. While Monte Rosa Therapeutics Inc 's total ranking has deteriorated compared to the previous quarter from 914 to 2046. Monte Rosa Therapeutics Inc has 150 employees.

What is Sales per Employee Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Revenue per Employee▼

None ▼

Revenue per Employee▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

GLUE Revenue per Employee	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter	(Mar 31 2025) I. Quarter
Y / Y Revenue Change	-95.04 %	-95.41 %	38.54 %	394.01 %	7882.05 %
Sales per Employee (TTM) $	286,353	824,480	1,210,253	1,186,573	1,063,247
GLUE's Total Ranking	# 2046	# 914	# 351	# 616	# 424
Seq. Revenue Change	51.38 %	-78.22 %	-44.95 %	-72.69 %	40.04 %

GLUE Company Profile >> Back to GLUE Efficiency Comparisons >> Compare GLUE Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within:	No.
Biotechnology & Pharmaceuticals Industry	# 32
Healthcare Sector	# 262
Overall Market	# 2046

Revenue per Employee Statistics
High	Average	Low
$ 1,210,253	$ 845,842	$ 286,353
(Sep 30 2025)		(Mar 31 2026)

Financial Statements
Monte Rosa Therapeutics Inc 's Revenue MRQ	$ 4 Millions	Visit GLUE's Income Statement
Monte Rosa Therapeutics Inc 's Revenues TTM	$ 43 Millions	Visit GLUE's aggregate revenue growth
What are GLUE's Sales?		Visit GLUE's Sales by Segment

Other Ratios
Monte Rosa Therapeutics Inc 's Income per Employee
Employees in Biotechnology & Pharmaceuticals
Biotechnology & Pharmaceuticals Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
GLUE's Revenue per Employee versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for GLUE's Competitors
Revenue per Employee for GLUE's Suppliers
Revenue per Employee for GLUE's Customers

You may also want to know
GLUE's Sales Growth Rates	GLUE's Pe Price to earnings ratio	GLUE's Receivables Turnover Ratio	GLUE's Stock Quote
GLUE's Net Income Growth Rates	GLUE's Ps Price to Sales ratio	GLUE's Sales per Employee	GLUE's Asset Turnover Ratio
GLUE's Net Margin	GLUE's Pb Price to Book ratio	GLUE's Financial Strength Ratios	GLUE's Dividend Payout Ratio

Date modified: 2026-08-30T15:02:21+00:00

Companies with similar Revenue per Employee for 12 months ending Mar 31 2026, within Healthcare Sector	Revenue per Employee	Revenue 12 months ending Mar 31 2026	Number of Employees Mar 31 2026
Zimmer Biomet Holdings Inc	494,652.94	$ 8,409.100 Million	17,000
Elanco Animal Health Incorporated	494,242.42	$ 4,893.000 Million	9,900
Arcturus Therapeutics Holdings Inc	492,882.88	$ 54.710 Million	111
Angiodynamics Inc	492,526.90	$ 311.277 Million	632
Verrica Pharmaceuticals Inc	488,960.53	$ 37.161 Million	76
Ultragenyx Pharmaceutical Inc	488,481.40	$ 669.708 Million	1,371
Verastem Inc	486,127.45	$ 49.585 Million	102
Viatris Inc	485,420.00	$ 14,562.600 Million	30,000
Avantor Inc	485,348.15	$ 6,552.200 Million	13,500
Alpha Pro Tech Ltd	485,048.78	$ 59.661 Million	123
Resmed Inc	484,132.81	$ 5,504.590 Million	11,370
Skinhealth Systems Inc	481,603.59	$ 295.223 Million	613
Mimedx Group Inc	479,762.38	$ 387.648 Million	808
Urogen Pharma Ltd	479,470.79	$ 139.526 Million	291
Beone Medicines Ltd	478,155.08	$ 5,737.861 Million	12,000
Waters Corporation	477,288.73	$ 3,770.581 Million	7,900
Adaptive Biotechnologies Corporation	473,408.65	$ 295.407 Million	624
Moderna Inc	473,404.26	$ 2,225.000 Million	4,700
Neuropace Inc	473,330.14	$ 98.926 Million	209
Ensysce Biosciences Inc	470,787.70	$ 4.708 Million	10
Maravai Lifesciences Holdings Inc	468,600.00	$ 203.841 Million	435
Biofrontera Inc	467,206.52	$ 42.983 Million	92
Inogen Inc	466,795.48	$ 351.497 Million	753
Butterfly Network Inc	466,540.91	$ 102.639 Million	220
Treace Medical Concepts Inc	460,706.67	$ 207.318 Million	450
Invivyd Inc	457,918.03	$ 55.866 Million	122
Lifemd Inc	457,247.95	$ 177.869 Million	389
Solana Company	456,619.05	$ 9.589 Million	21
Stryker Corp	451,250.00	$ 25,270.000 Million	56,000
Cumberland Pharmaceuticals Inc	450,964.44	$ 41.940 Million	93

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.